Assessment of affective and somatic signs of ethanol withdrawal in C57BL/6J mice using a short-term ethanol treatment

• Published in: Alcohol (Fayetteville, N.Y.) N.Y.), 2015-05, Vol.49 (3), p.237-243
• Main Authors: Perez, E.E, De Biasi, M
• Format: Article
• Language: English
• Subjects: Affect - drug effects; Alcohol; Animals; Anxiety; Anxiety - chemically induced; Anxiety - psychology; Anxiety-like behavior; Behavior; Behavior, Animal - drug effects; Central Nervous System Depressants - adverse effects; Central Nervous System Depressants - pharmacology; Compulsive Behavior - chemically induced; Compulsive Behavior - psychology; Compulsive-like behavior; Dehydrogenases; Diet; Ethanol; Ethanol - adverse effects; Ethanol - pharmacology; Female; Grooming - drug effects; Housing; Intubation; Light; Male; Mastication - drug effects; Mice; Mice, Inbred C57BL; Mortality; Mouse; Paradigms; Psychiatry; Somatic signs; Substance Withdrawal Syndrome - etiology; Substance Withdrawal Syndrome - physiopathology; Substance Withdrawal Syndrome - psychology; Vocalization, Animal - drug effects; Withdrawal
• ISSN: 0741-8329; 1873-6823
• DOI: 10.1016/j.alcohol.2015.02.003

Abstract Alcohol is one of the most prevalent addictive substances in the world. Withdrawal symptoms result from abrupt cessation of alcohol consumption in habitual drinkers. The emergence of both affective and physical symptoms produces a state that promotes relapse. Mice provide a preclinical model that could be used to study alcohol dependence and withdrawal while controlling for both genetic and environmental variables. The use of a liquid ethanol diet offers a reliable method for the induction of alcohol dependence in mice, but this approach is impractical when conducting high-throughput pharmacological screens or when comparing multiple strains of genetically engineered mice. The goal of this study was to compare withdrawal-associated behaviors in mice chronically treated with a liquid ethanol diet vs. mice treated with a short-term ethanol treatment that consisted of daily ethanol injections containing the alcohol dehydrogenase inhibitor, 4-methylpyrazole. Twenty-four hours after ethanol treatment, mice were tested in the open field arena, the elevated plus maze, the marble burying test, or for changes in somatic signs during spontaneous ethanol withdrawal. Anxiety-like and compulsive-like behaviors, as well as physical signs, were all significantly elevated in mice undergoing withdrawal, regardless of the route of ethanol administration. Therefore, a short-term ethanol treatment can be utilized as a screening tool for testing genetic and pharmacological agents before investing in a more time-consuming ethanol treatment.